The Urology Group (Solaris)

Cincinnati, Ohio 45212

1 studies enrolling now · 1 studies all time

What they study most

High-Risk Non-Muscle-Invasive Bladder Cancer

Studies at this site

• Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC — Recruiting now